Amyloid-beta and tau are the two proteins that define Alzheimer's disease. Amyloid-beta accumulates first, and is thought to trigger the spread of tau pathology through connected brain regions over…
Blood-based biomarkers are increasingly used to support Alzheimer’s disease diagnosis, but many patients also have cerebral small vessel disease, a common vascular brain pathology. ISD researchers…
Ali Erturk and his team have developed an artificial intelligence (AI) framework that maps disease-related changes throughout the entire mouse body at cellular resolution. Using MouseMapper, the…
